487 related articles for article (PubMed ID: 33178188)
1. Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles.
Goldenson BH; Zhu H; Wang YM; Heragu N; Bernareggi D; Ruiz-Cisneros A; Bahena A; Ask EH; Hoel HJ; Malmberg KJ; Kaufman DS
Front Immunol; 2020; 11():561553. PubMed ID: 33178188
[TBL] [Abstract][Full Text] [Related]
2. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
[TBL] [Abstract][Full Text] [Related]
3. NK cell development in a human stem cell niche: KIR expression occurs independently of the presence of HLA class I ligands.
Zhao X; Weinhold S; Brands J; Hejazi M; Degistirici Ö; Kögler G; Meisel R; Uhrberg M
Blood Adv; 2018 Oct; 2(19):2452-2461. PubMed ID: 30266820
[TBL] [Abstract][Full Text] [Related]
4. IL-12 directs further maturation of ex vivo differentiated NK cells with improved therapeutic potential.
Lehmann D; Spanholtz J; Sturtzel C; Tordoir M; Schlechta B; Groenewegen D; Hofer E
PLoS One; 2014; 9(1):e87131. PubMed ID: 24498025
[TBL] [Abstract][Full Text] [Related]
5. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
Front Immunol; 2021; 12():640672. PubMed ID: 34017328
[TBL] [Abstract][Full Text] [Related]
6. Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15.
McCullar V; Oostendorp R; Panoskaltsis-Mortari A; Yun G; Lutz CT; Wagner JE; Miller JS
Exp Hematol; 2008 May; 36(5):598-608. PubMed ID: 18295962
[TBL] [Abstract][Full Text] [Related]
7. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
Rajagopalan S; Long EO
J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
[TBL] [Abstract][Full Text] [Related]
8. Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I.
Schönberg K; Fischer JC; Kögler G; Uhrberg M
Blood; 2011 May; 117(19):5152-6. PubMed ID: 21415265
[TBL] [Abstract][Full Text] [Related]
9. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.
Della Chiesa M; Falco M; Bertaina A; Muccio L; Alicata C; Frassoni F; Locatelli F; Moretta L; Moretta A
J Immunol; 2014 Feb; 192(4):1471-9. PubMed ID: 24442432
[TBL] [Abstract][Full Text] [Related]
10. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.
Shilling HG; McQueen KL; Cheng NW; Shizuru JA; Negrin RS; Parham P
Blood; 2003 May; 101(9):3730-40. PubMed ID: 12511415
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals.
Grau R; Lang KS; Wernet D; Lang P; Niethammer D; Pusch CM; Handgretinger R
Exp Mol Pathol; 2004 Apr; 76(2):90-8. PubMed ID: 15010286
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells.
Igarashi T; Wynberg J; Srinivasan R; Becknell B; McCoy JP; Takahashi Y; Suffredini DA; Linehan WM; Caligiuri MA; Childs RW
Blood; 2004 Jul; 104(1):170-7. PubMed ID: 15016654
[TBL] [Abstract][Full Text] [Related]
13. Generation of "Off-the-Shelf" Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells.
Zeng J; Tang SY; Toh LL; Wang S
Stem Cell Reports; 2017 Dec; 9(6):1796-1812. PubMed ID: 29173894
[TBL] [Abstract][Full Text] [Related]
14. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
[TBL] [Abstract][Full Text] [Related]
15. Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.
Cooley S; Parham P; Miller JS
Blood; 2018 Mar; 131(10):1053-1062. PubMed ID: 29358179
[TBL] [Abstract][Full Text] [Related]
16. KIR/HLA interactions negatively affect rituximab- but not GA101 (obinutuzumab)-induced antibody-dependent cellular cytotoxicity.
Terszowski G; Klein C; Stern M
J Immunol; 2014 Jun; 192(12):5618-24. PubMed ID: 24795454
[TBL] [Abstract][Full Text] [Related]
17. KIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules.
Gwozdowicz S; Nestorowicz K; Graczyk-Pol E; Szlendak U; Rogatko-Koros M; Mika-Witkowska R; Pawliczak D; Zubala M; Malinowska A; Witkowska A; Nowak J
Int J Immunogenet; 2019 Aug; 46(4):217-231. PubMed ID: 31210416
[TBL] [Abstract][Full Text] [Related]
18. [KIRs on human NK cells and in relation with HLA class I antigen--review].
Dou LP; Da WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):627-30. PubMed ID: 16800958
[TBL] [Abstract][Full Text] [Related]
19. Production of cytotoxic, KIR-negative NK cells from CD34+ cord blood cells with the use of Notch signaling.
Beck RC
Transfusion; 2011 Nov; 51 Suppl 4():145S-152S. PubMed ID: 22074625
[TBL] [Abstract][Full Text] [Related]
20. High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status.
Veluchamy JP; Heeren AM; Spanholtz J; van Eendenburg JD; Heideman DA; Kenter GG; Verheul HM; van der Vliet HJ; Jordanova ES; de Gruijl TD
Cancer Immunol Immunother; 2017 Jan; 66(1):51-61. PubMed ID: 27783105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]